Tumour shrinkage during proton-based chemoradiation for non-small-cell lung cancer may necessitate adaptive replanning during treatment

Hong Kong Journal of Radiology

Volumn 14, Issue 3, 2011, Pages 190-194

  Shi, W ^a   Nichols Jr , Romaine C ^b   Flampouri, S ^b   Hsi, W ^b   Li, Z ^b   Henderson, R H ^b   Mendenhall, N P ^a   Hoppe, B ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Carcinoma, non small cell lung; Lung neoplasms; Protons; Radiotherapy planning, computed assisted

Indexed keywords

CARBOPLATIN; COBALT; PACLITAXEL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; ESOPHAGUS; HUMAN; HUMAN TISSUE; LUNG; LUNG NON SMALL CELL CANCER; PHYSICIAN; PROTON RADIATION; RADIATION DOSE; RADIOGRAPHY; RISK; SPINAL CORD; TUMOR REGRESSION;

EID: 82755167224     PISSN: 22236619     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kang Y, Zhang X, Chang JY, Wang H, Wei X, Liao Z, et al. 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys. 2007;67:906-14. (Pubitemid 46215899)
2. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzerider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109-22.
3. Moyers MF, Miller DW, Bush DA, Slater JD. Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys. 2001;49:1429-38. (Pubitemid 32294322)
4. Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformai or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;65:1087-96.
5. Zhang X, Li Y, Pan X, Xiaoqiang L, Mohan R, Komaki R, et al. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. Int J Radiat Oncol Biol Phys. 2010;77:357-66.
6. Widesott L, Amichetti M, Schwarz M. Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review. Radiother Oncol. 2008;86:154-64.
7. DeLaney TF. Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center. Technol Cancer Res Treat. 2007;6(4Suppl):S61-6.
8. Hata M, Tokuuye K, Kagei K, Sugahara S, Nakayama H, Fukumitsu N, et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int J Radiat Oncol Biol Phys. 2007;68:786-93. (Pubitemid 46818733)
9. Engelsman M, Kooy HM. Target volume dose considerations in proton beam treatment planning for lung tumors. Med Phys. 2005;32:3549-57.
10. Kupelian PA, Ramsey C, Meeks SL, Willoughby TR, Forbes A, Wagner TH, et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys. 2005;63:1024-8. (Pubitemid 41505279)
11. Ramsey CR, Langen KM, Kupelian PA, Scaperoth DD, Meeks SL, Mahan SL, et al. A technique for adaptive image-guided helical tomotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2006;64:123744.
12. Woodford C, Yartsev S, Dar AR, Bauman G, Van Dyk J. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images. Int J Radiat Oncol Biol Phys. 2007;69:1316-22. (Pubitemid 47625877)
13. Zhang H, Hyrien O, Pandya KJ, Keng PC, Chen Y. Tumor response kinetics after schedule-dependent paclitaxel chemoradiation treatment for inoperable non-small cell lung cancer: a model for low-dose chemotherapy radiosensitization. J Thorac Oncol. 2008;3:563-8. (Pubitemid 351787297)
14. Seibert RM, Ramsey CR, Hines JW, Kupelian PA, Langen KM, Meeks SL, et al. A model for predicting lung cancer response to therapy. Int J Radiat Oncol Biol Phys. 2007;67:601-9. (Pubitemid 46108331)
15. Gueulette J, Bohm L, Slabbert JP, De Coster BM, Rutherfoord GS, Ruifrok A, et al. Proton relative biological effectiveness (RBE) for survival in mice after thoracic irradiation with fractionated doses. Int J Radiat Oncol Biol Phys. 2000;47:1051-8. (Pubitemid 30345606)